Photo from Albert Grinshpun/X
Jul 3, 2024, 01:37
Albert Grinshpun: Another important sub-population which might enjoy life without chemo
Albert Grinshpun, Goldfarb Advanced Breast Cancer Fellow at the Breast Oncology Center of Dana-Farber Cancer Institute shared a post by Yakub Ergün, Medical Oncologist at Antalya City Hospital on X:
“In addtion to the great data from ATEMPT by Paolo Tarantino and Sara Morishige, another important sub-population which might enjoy life without chemo.”
Quoting Yakub Ergün’s post on X:
“Tumor-Infiltrating Lymphocytes in Stage I TNBC Untreated With Chemotherapy.
Patients with pT1c TNBC tumors and sTIL levels ≥50% had a 10-year survival of 95% without chemotherapy, increasing to 98% with sTIL levels ≥75%.”
Source: Albert Grinshpun/X and Yakub Ergün/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 15, 2024, 15:10
Nov 15, 2024, 14:53
Nov 15, 2024, 14:17
Nov 15, 2024, 14:11